Search

everythinglearnresearchcommunity

for

Search:↓

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

PTHRP agonists can stimulate hair growth, especially in damaged follicles, while antagonists may initially increase growth but ultimately inhibit it.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Lower SHBG levels may increase the risk of PCOS.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Tamoxifen caused hair loss in a 52-year-old woman.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.

Different hair loss patterns may be linked to varying male hormone levels.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Phthirusa pyrifolia extract may lower testosterone and harm male rat reproduction without damaging the liver or kidneys.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.